Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 3 (March)

1. A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
   Clin Cancer Res, 13(5): 1516-22. [Abstract] [Full-text]
2. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
   Clin Cancer Res, 13(5): 1383-8. [Abstract] [Full-text]
3. Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection.
   Expert Rev Mol Diagn, 7(2): 117-31. [Abstract] [Full-text]
4. Initial Experience with the Quality Assurance Program of Radiation Therapy on behalf of Japan Radiation Oncology Group (JAROG).
   Jpn J Clin Oncol, 37(2): 135-9. [Abstract] [Full-text]
5. Phase II multi-step planning methods in oncology: comparison, recommendations and potential applications.
   Contemp Clin Trials, 28(3): 249-57. [Abstract] [Full-text]
6. The impact of a supplementary medication review and counselling service within the oncology outpatient setting.
   Br J Cancer, 96(5): 744-51. [Abstract] [Full-text]
7. Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task force.
   Crit Rev Oncol Hematol, 62(1): 62-73. [Abstract] [Full-text]
8. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
   Blood, 109(6): 2314-21. [Abstract] [Full-text]
9. Complementary/alternative medicine use in a pediatric oncology unit in Turkey.
   Pediatr Blood Cancer, 48(5): 540-3. [Abstract] [Full-text]
10. Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III.
    Pediatr Blood Cancer, 48(5): 598-9. [Abstract] [Full-text]
11. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.
    Pediatr Blood Cancer, 48(5): 521-6. [Abstract] [Full-text]
12. Evaluation of pediatric oncology patients with previous multiple central catheters for vascular access: is Doppler ultrasound needed?
    Pediatr Blood Cancer, 48(5): 527-31. [Abstract] [Full-text]
13. Views of oncology patients, their relatives and oncologists on cardiopulmonary resuscitation (CPR): questionnaire-based study.
    Palliat Med, 21(2): 139-44. [Abstract] [Full-text]
14. International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.
    Eur J Cancer, 43(5): 852-8. [Abstract] [Full-text]
15. A survey of the management of neutropenic fever in oncology units in the UK.
    Int J Antimicrob Agents, 29(4): 430-3. [Abstract] [Full-text]
16. Biomarkers in drug development: friend or foe? A personal reflection gained working within oncology.
    Pharm Stat. [Abstract] [Full-text]
17. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells Yuan X, Li T, Wang H, Zhang T, Barua M, Borgesi RA, Bubley GJ, Lu ML, Balk SP, Hematology/Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA.
    Urol Oncol, 25(2): 178-9. [Abstract] [Full-text]
18. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure Geldart TR, Gale J, McKendrick J, Kirby J, Mead G, Medical Oncology Unit, Southhampton University Hospitals NHS Trust, Southhampton, United Kingdom.
    Urol Oncol, 25(2): 172-3. [Abstract] [Full-text]
19. Improving patient safety and communication through care rounds in a pediatric oncology outpatient clinic.
    J Nurs Care Qual, 22(2): 159-63. [Abstract] [Full-text]
20. Risk Items Associated With Patient Falls in Oncology and Medical Settings.
    J Nurs Care Qual, 22(2): 130-137. [Abstract] [Full-text]
21. GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trials.
    J Neurooncol, 82(2): 211-20. [Abstract] [Full-text]
22. Investigating the cost-effectiveness of videotelephone based support for newly diagnosed paediatric oncology patients and their families: design of a randomised controlled trial.
    BMC Health Serv Res, 7: 38. [Abstract] [Full-text]
23. A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
    Clin Cancer Res, 13(6): 1789-93. [Abstract] [Full-text]
24. Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study.
    Clin Cancer Res, 13(6): 1783-8. [Abstract] [Full-text]
25. Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study.
    Int J Gynecol Cancer, 17(2): 387-93. [Abstract] [Full-text]
26. Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study.
    Int J Gynecol Cancer, 17(2): 359-66. [Abstract] [Full-text]
27. How do participants of a post registration oncology nursing course perceive that the course influences their practice?--A descriptive survey.
    Eur J Oncol Nurs, 11(2): 168-78. [Abstract] [Full-text]
28. Distinguishing Undifferentiated Embryonal Sarcoma of the Liver from Biliary Tract Rhabdomyosarcoma: A Children's Oncology Group Study.
    Pediatr Dev Pathol, 10(2): 89-97. [Abstract] [Full-text]
29. The Problems and Promise of Central Pathology Review: Development of a Standardized Procedure for the Children's Oncology Group.
    Pediatr Dev Pathol. [Abstract] [Full-text]
30. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: A Gynecologic Oncology Group study.
    Gynecol Oncol, 105(1): 59-65. [Abstract] [Full-text]
31. Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.
    Urology, 69(3): 505-9. [Abstract] [Full-text]
32. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    J Clin Pharm Ther, 32(2): 169-75. [Abstract] [Full-text]
33. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.
    J Magn Reson Imaging, 25(4): 848-58. [Abstract] [Full-text]
34. Alternative splicing: an emerging topic in molecular and clinical oncology.
    Lancet Oncol, 8(4): 349-57. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.